Ruxolitinib Phosphate, sold under the brand names Jakafi and Jakavi, is a medication for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow.Ruxolitinib is a janus-associated kinase inhibitor indicated to treat bone marrow cancer, specifically intermediate or high-risk myelofibrosis. Reference standards of Ruxolitinib Phosphate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Ruxolitinib Phosphate - API Standards [catalogue_number] => PA 18 1110000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 404.37 [form] => C17H21N6O4P [cas] => 1092939-17-7 [pslug] => 1092939-17-7-ruxolitinib-phosphate-api-pa181110000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 42184 [offers_product_code] => PA 18 1110000 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 18 1110000
CAS :
Molecular Formula : C17H21N6O4P
Molecular Weight : 404.37
stdClass Object ( [pname] => (S)-Ruxolitinib Phosphate [catalogue_number] => PA 18 1111000 [category_ids] => 76,70,75,78,82 [chemical_name] => [weight] => 404.37 [form] => C17H21N6O4P [cas] => 2703484-89-1 [pslug] => 2703484-89-1-s-ruxolitinib-phosphate-pa181111000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 42185 [offers_product_code] => PA 18 1111000 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 18 1111000
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
